Demographic, clinical, and serological features of Turkish patients with rheumatoid arthritis: evaluation of 165 patients.
The study was designed to describe demographic, clinical, serological, and radiological characteristics of patients with rheumatoid arthritis (RA) followed-up by a single institution. One hundred sixty-five patients, diagnosed as RA using ACR classification criteria, and followed-up in the rheumatology clinic between December 2005 and January 2010, were enrolled in the study. Of the patients, 125 were female, and 40 were male. Mean age of the patients was 52.5 years, and mean duration of the disease was 10.5 years. The most frequently involved joints were the wrist (95.2%), MCP (90.9%), and the PIP (92.6%). The knee and hip joint involvement rates were 44.8% and 23.6%, respectively. Patients (50.9%) were detected to have tenosynovitis. Involvement of the elbow joint was shown in 10.9% of the patients. The most common extra-articular manifestations were sicca symptom (40.6%) and carpal tunnel syndrome (35.7%), followed by pulmonary involvement (6.6%), vasculitis (3.6%), and Raynaud's phenomenon (1.2%). Rheumatoid nodules were detected in six patients (3.6%). One patient had Felty syndrome, and another patient had secondary amyloidosis. Patients (90.3%) had positive rheumatoid factor (RF), and 124 patients had positive anti-CCP antibody (75.2%). A more severe clinical course and a higher incidence of erosion, tenosynovitis, and deformities were detected in patients with anti-CCP antibody and positive RF (p = 0.03, p = 0.04, p = 0.01, p = 0.04, respectively). The wrist was the most frequently involved joint in our patients, and the most frequently seen extra-articular manifestation was sicca symptom. Presence of RF and anti-CCP antibody was associated with more severe disease including erosive and destructive arthropathy. Extra-articular involvement and presence of accompanying diseases increase the mortality.
Department of Rheumatology, Manisa Hospital, Manisa Devlet Hastanesi, Manisa, Turkey. senolkobak@yahoo.com
Senol
S
Kobak
D000888:Antibodies, Anti-Idiotypic / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000000981:diagnostic imaging / Q000453:epidemiology*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000378:metabolism; D002349:Carpal Tunnel Syndrome / Q000453:epidemiology; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008171:Lung Diseases / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000276:immunology*; D011859:Radiography; D011928:Raynaud Disease / Q000453:epidemiology; D012189:Retrospective Studies; D012217:Rheumatoid Factor / Q000097:blood*; D012859:Sjogren's Syndrome / Q000453:epidemiology*; D013717:Tenosynovitis / Q000453:epidemiology*; D014421:Turkey / Q000453:epidemiology; D014657:Vasculitis / Q000453:epidemiology
D000888:Antibodies, Anti-Idiotypic; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D002097:C-Reactive Protein; D012217:Rheumatoid Factor
J Rheumatol. 1992 Feb;19(2):242-6
1629822
Clin Biochem. 2006 Oct;39(10):961-5
16979149
Med Princ Pract. 2004 Jan-Feb;13(1):47-50
14657620
Arthritis Rheum. 1992 Jul;35(7):745-8
1622412
Br J Rheumatol. 1993 Jul;32(7):541-5
8339122
Clin Rheumatol. 2008 Sep;27(9):1119-25
18357499
Arthritis Rheum. 1988 Mar;31(3):315-24
3358796
Semin Arthritis Rheum. 1997 Oct;27(2):123-40
9355210
Clin Rheumatol. 1995 Nov;14(6):641-5
8608681
Rheumatol Int. 1983;3(3):105-8
6583817
Ann Intern Med. 1996 Apr 15;124(8):699-707
8633829
Rheumatol Int. 1993;13(4):131-4
8310203
Clin Exp Rheumatol. 2006 May-Jun;24(3):305-8
16870099
Br J Rheumatol. 1996 Oct;35(10):994-9
8883439
Ann Rheum Dis. 2007 Nov;66(11):1491-6
17412740
Ter Arkh. 1999;71(5):9-12
10399221